Document Detail


Identification of a novel NCF-1 (p47-phox) pseudogene not containing the signature GT deletion: significance for A47 degrees chronic granulomatous disease carrier detection.
MedLine Citation:
PMID:  12176908     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The p47-phox gene, NCF-1, has 2 nearly identical pseudogenes (psiNCF-1) in proximity at chromosomal locus 7q11.23. A dinucleotide deletion (DeltaGT) at the beginning of exon 2 that leads to a frameshift and premature stop codon is considered the signature sequence of the pseudogenes. It is also the most prevalent mutation in p47-phox-deficient (A47 degrees ) chronic granulomatous disease (CGD) as a result of the insertion of a DeltaGT-containing fragment of pseudogene into NCF-1. Extending our study of the relationship between NCF-1 and psiNCF-1 to 53 unaffected control individuals, we found that although in most (n = 44), the ratio of pseudogene (DeltaGT) to functional gene (GTGT) sequence in amplicons spanning exon 2 was 2:1, as previously observed, surprisingly, in 7 persons the ratio was 1:1, and in 2 persons the ratio was 1:2. The lowered ratios are explained by the presence, in a heterozygous or homozygous state, respectively, of a pseudogene that contains GTGT rather than DeltaGT. It is possible that this pseudogene has not undergone deletion of GT, but more likely, based on analysis of additional NCF-1/psiNCF-1 markers, it represents the previously unidentified product of the reciprocal crossover of DNA fragments between the functional gene and one of its pseudogenes. The mutated NCF-1 resulting from this event is the predominant A47 degrees CGD allele. The existence of 2 extended haplotypes encompassing NCF-1/psiNCF-1 further complicates the detection of A47 degrees CGD carriers. Although most have a DeltaGT/GTGT ratio of 5:1, some have a ratio of 2:1 and are indistinguishable by this means from unaffected individuals.
Authors:
Paul G Heyworth; Deborah Noack; Andrew R Cross
Related Documents :
11606548 - Dna dinucleotide evolution in humans: fitting theory to facts.
2990828 - Organization and chromosomal specificity of autosomal homologs of human y chromosome re...
15197728 - Chromosome translocation induced by the insertion of the ura blaster into the major rep...
17855568 - Multiple-locus variable-number tandem-repeat analysis for rapid typing of candida glabr...
11101848 - A major susceptibility locus for atopic dermatitis maps to chromosome 3q21.
12571788 - Refractory photosensitive epilepsy associated with a complex rearrangement of chromosom...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Blood     Volume:  100     ISSN:  0006-4971     ISO Abbreviation:  Blood     Publication Date:  2002 Sep 
Date Detail:
Created Date:  2002-08-14     Completed Date:  2002-09-13     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7603509     Medline TA:  Blood     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1845-51     Citation Subset:  AIM; IM    
Affiliation:
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA. heyworth@scripps.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chromosomes, Human, Pair 7*
Genome, Human
Granulomatous Disease, Chronic / genetics*
Heterozygote
Humans
NADPH Oxidase
Phosphoproteins / genetics*
Pseudogenes*
Sequence Deletion
Grant Support
ID/Acronym/Agency:
AI24838/AI/NIAID NIH HHS; CA68276/CA/NCI NIH HHS; RR00833/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Phosphoproteins; EC 1.6.3.1/NADPH Oxidase; EC 1.6.3.1/neutrophil cytosolic factor 1
Comments/Corrections
Comment In:
Blood. 2003 Apr 15;101(8):3337   [PMID:  12672696 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inhibitory effects of a dominant-interfering form of the Rho-GTPase Cdc42 in the chemoattractant-eli...
Next Document:  SHP-1 regulates Fcgamma receptor-mediated phagocytosis and the activation of RAC.